Related Experiment Video
Updated: Nov 7, 2025

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
Can miRNA Indicate Risk of Illness after Continuous Exposure to M. tuberculosis?
Cleonardo Augusto Silva1,2, Arthur Ribeiro-Dos-Santos1, Wanderson Gonçalves Gonçalves1,2
1PPG em Genética e Biologia Molecular, Laboratório de Genética Humana e Médica, Universidade Federal do Pará, Belém 66075-110, Brazil.
Abstract:
The role of regulatory elements such as small ncRNAs and their mechanisms are poorly understood in infectious diseases. Tuberculosis is one of the oldest infectious diseases of humans and it is still a challenge to prevent and treat. Control of the infection, as well as its diagnosis, are still complex and current treatments used are linked to several side effects. This study aimed to identify possible biomarkers for tuberculosis by applying NGS techniques to obtain global miRNA expression profiles from 22 blood samples of infected patients with tuberculosis (n = 9), their respective healthy physicians (n = 6) and external healthy individuals as controls (n = 7). Samples were run through a pipeline consisting of differential expression, target genes, gene set enrichment and miRNA-gene network analyses. We observed 153 altered miRNAs, among which only three DEmiRNAs (hsa-let-7g-5p, hsa-miR-486-3p and hsa-miR-4732-5p) were found between the investigated patients and their respective physicians. These DEmiRNAs are suggested to play an important role in granuloma regulation and their immune physiopathology. Our results indicate that miRNAs may be involved in immune modulation by regulating gene expression in cells of the immune system. Our findings encourage the application of miRNAs as potential biomarkers for tuberculosis.
Insights
This study explored microRNAs (miRNAs) as potential biomarkers for tuberculosis. Three specific miRNAs were identified, suggesting their role in immune response and disease regulation for improved tuberculosis diagnosis.
Area of Science:
- Molecular Biology
- Immunology
- Infectious Diseases
Background:
- MicroRNAs (miRNAs) are crucial regulatory elements in biological processes, but their role in infectious diseases like tuberculosis remains unclear.
- Tuberculosis (TB) presents significant challenges in prevention, diagnosis, and treatment, with current therapies causing side effects.
- Identifying novel biomarkers is essential for improving TB management.
Purpose of the Study:
- To identify potential biomarkers for tuberculosis using next-generation sequencing (NGS) techniques.
- To investigate global miRNA expression profiles in tuberculosis patients compared to healthy controls.
- To explore the role of differentially expressed miRNAs in the immune physiopathology of tuberculosis.
Main Methods:
- Collected blood samples from tuberculosis patients (n=9), their healthy physicians (n=6), and external healthy controls (n=7).
- Applied NGS to obtain global miRNA expression profiles.
- Utilized differential expression analysis, target gene prediction, gene set enrichment, and miRNA-gene network analyses.
Main Results:
- Identified 153 differentially expressed miRNAs.
- Found three specific differentially expressed miRNAs (hsa-let-7g-5p, hsa-miR-486-3p, and hsa-miR-4732-5p) between tuberculosis patients and their physicians.
- These miRNAs are implicated in granuloma regulation and immune response.
Conclusions:
- MicroRNAs play a role in immune modulation by regulating gene expression in immune cells.
- The identified miRNAs show potential as biomarkers for tuberculosis diagnosis and understanding disease mechanisms.
- Further research into miRNAs could lead to improved diagnostic tools and therapeutic strategies for tuberculosis.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

